Tourmaline Oil has a total of 42 patents globally, out of which 19 have been granted. Of these 42 patents, more than 4% patents are active. United States of America is where Tourmaline Oil has filed the maximum number of patents, followed by Japan and Australia. Parallelly, United States of America seems to be the main focused R&D centre and Canada is the origin country of Tourmaline Oil.
Tourmaline Oil was founded in the year 2008. The Company is an intermediate crude oil and natural gas exploration and production company. The Company is focused on long-term growth through an aggressive exploration, development, production and acquisition program in the Western Canadian Sedimentary Basin. As of March 2023, the market cap of Tourmaline Oil is $13.71 Billion.
Do read about some of the most popular patents of Tourmaline Oil which have been covered by us in this article and also you can find Tourmaline Oil patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Tourmaline Oil patent portfolio.
How many patents does the founder and the CEO of Tourmaline Oil have?
The founder and CEO Michael Rose has 29 patents.
How many patents does Tourmaline Oil have?
Tourmaline Oil has a total of 42 patents globally. These patents belong to 13 unique patent families. Out of 42 patents, 2 patents are active.
How Many Patents did Tourmaline Oil File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Tourmaline Oil Applications Filed | Tourmaline Oil Patents Granted |
| 2009 | – | 1 |
| 2008 | – | 2 |
| 2006 | 2 | – |
| 2005 | 1 | 1 |
| 2004 | – | 3 |
| 2003 | – | 5 |
| 2002 | 1 | 7 |
How many Tourmaline Oil patents are Alive/Dead?
How Many Patents did Tourmaline Oil File in Different Countries?
Countries in which Tourmaline Oil Filed Patents
| Country | Patents |
| United States Of America | 9 |
| Japan | 9 |
| Australia | 4 |
| Germany | 3 |
| Europe | 3 |
| Spain | 2 |
| Taiwan | 2 |
| Austria | 2 |
| Canada | 1 |
| China | 1 |
| Denmark | 1 |
| New Zealand | 1 |
| Mexico | 1 |
Where are Research Centres of Tourmaline Oil Patents Located?
10 Best Tourmaline Oil Patents
US6350617B1 is the most popular patent in the Tourmaline Oil portfolio. It has received 54 citations so far from companies like Samsung, Cytonome and Agilent Technologies.
Below is the list of 10 most cited patents of Tourmaline Oil:
| Publication Number | Citation Count |
| US6350617B1 | 54 |
| US7559373B2 | 26 |
| US6723235B2 | 18 |
| US20020043624A1 | 13 |
| US6720190B1 | 10 |
| TW539856B | 10 |
| US6358930B1 | 5 |
| JP2006213735A | 3 |
| JP2002522445A | 2 |
| JP2002503708A | 2 |
List of Tourmaline Oil Patents
| Tourmaline Oil Patents | Title |
| US7559373B2 | Process For Fracturing A Subterranean Formation |
| US6723235B2 | Apparatus For Screening Compound Libraries |
| US6720190B1 | Methods For Screening Compound Libraries |
| US6528274B1 | Method For The Production Of Sialylated Oligosaccharides |
| US6358930B1 | Treatment Of C. Difficile Toxin B Associated Conditions |
| US6350617B1 | Device For Delivery Of Multiple Liquid Sample Streams To A Mass Spectrometer |
| US20020111481A1 | Processes For The Preparation Of Alphagal(1-4)Betagal(1-4)Glc-Or Trisaccharides |
| US20020099186A1 | Processes For The Preparation Of Alphagal(1-3)Betagal(1-4)Glc-Or |
| US20020043624A1 | Device For Delivery Of Multiple Liquid Sample Streams To A Mass Spectrometer |
| EP0744959B1 | Treatment Of Antibiotic Associated Diarrhea |
| EP0937092B1 | Solid Support Matrices Containing A Toxin Binding Oligosaccharide |
| EP1250153A2 | Treatment Of I C. Difficile /I Toxin B Associated Conditions |
| CN1131070C | Method For Removal Virus A. And Pharmacal Composite For Treating Disease Caused By Virus A. |
| WO2002048163A3 | Processes For The Preparation Of Alpha Gal(1}4) Beta Gal(1}4)Glc-Or Trisaccharides |
| WO2002044190A3 | Processes For The Preparation Of Alpha Gal(1}3) Beta Gal(1}4)Glc-Or |
| WO2001032219A3 | Treatment Of C. Difficile Toxin B Associated Conditions |
| DE69533084T2 | Treatment Of Antibiotic-Associated Diarrhea |
| DE69713514T2 | Solid Phase Support Surface That Contain Toxin-Binding Oligosaccharides |
| DE1089740T1 | Treatment Of Conditions Associated With C. Difficile Toxin B |
| ES2183150T3 | Solid Support Matrices Containing A Toxin Binding Oligosaccharide |
| ES2174404T3 | Apparatus For Screening Compound Libraries |
| DK0937092T3 | Solid Carrier Matrices Containing An Oligosaccharide Which Binds Toxins |
| JP4122052B2 | Treatment Of Antibiotic-Associated Diarrhea |
| JP2003513051A5 | C.Treatment Of Difficile Toxin B-Related Conditions |
| JP2006213735A | Treatment Of C. Difficile Toxin B Associated Condition |
| JP2002516284A5 | C.Treatment Of Difficile Toxin B-Related Conditions |
| JP2002524084A | Method For Purifying Sialylated Oligosaccharides |
| JP2002522445A | Solid-Phase Synthesis Of Thio-Oligosaccharides |
| JP2002514652A | 1-Galactose Derivative |
| JP2002503708A | Compositions And Methods For The Treatment Of Shigellosis Using Antibiotics And Toxin-Binding Oligosaccharide Compositions |
| JP2002502382A | Method For Recovering Shiga-Like Toxin And Vaccine Containing Inactivated Shiga-Like Toxin |
| AU2002215724A1 | Processes For The Preparation Of Alphagal(1’4)Betagal(1’4)Glc-Or Trisaccharides |
| AU2002015724A1 | Processes For The Preparation Of Alphagal(1-4)Betagal(1-4)Glc-Or Trisaccharides |
| AU2002221399A1 | Processes For The Preparation Of Alphagal(1’3)Betagal(1’4)Glc-Or |
| AU2002021399A1 | Processes For The Preparation Of Alphagal(1-3)Betagal(1-4)Glc-Or |
| TW539856B | Electrospray Device For A Mass Spectrometer And Method Of Delivering A Plurality Of Sample Streams To A Mass Spectrometer For Sequential Analysis |
| TW474814B | Pharmaceutical Compositions Useful In Treating Traveller’S Diarrhea And Related Conditions Initiated By Enterotoxigenic E. Coli |
| AT267614T | Treatment Of Antibiotic-Associated Diarrhea |
| AT219496T | Solid Phase Support Surface That Contain Toxin-Binding Oligosaccharides |
| CA2517497C | Well Product Recovery Process |
| NZ504303B | Compounds And Methods For The Treatment Of Bacterial Dysentery Using Antibiotics And Toxin Binding Oligosaccharide Compositions |
| MXPA00006293A | Compounds And Methods For The Treatment Of Bacterial Dysentery Using Antibiotics And Toxin-Binding Oligosaccharide Compositions. |